GCM
ICVX

Gladius Capital Management’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Gladius Capital Management’s Portfolio ICVX Stock Details ICVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-11,010
Closed -$87.4K – 443
2022
Q4 		$87.4K Buy
11,010
+3,182
+41% +$13.7K 0.01% 178
2022
Q3 		$25K Buy
+7,828
New +$49K ﹤0.01% 319

Other funds holding ICVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Gladius Capital Management's ICVX Position: Q1 2023 in Review

Gladius Capital Management sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2023, closing a stake of 11,010 shares — an estimated $87.4K sold.

Gladius Capital Management first reported a position in ICVX in Q3 2022 and held it in 2 quarters. The position peaked at $87.4K in Q4 2022. 66 funds tracked by Wall St. Rank hold ICVX as of Q1 2023.

  • Gladius Capital Management reported no remaining Icosavax, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Gladius Capital Management sold 11,010 Icosavax, Inc. Common Stock shares in Q1 2023, an estimated $87.4K.
  • Gladius Capital Management first reported a position in Icosavax, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
  • Gladius Capital Management's Icosavax, Inc. Common Stock position peaked at $87.4K in Q4 2022.
  • 66 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2023.

Based on Gladius Capital Management's 13F filing for Q1 2023, filed 9 May 2023.